AU1043201A - Cyclosporin formulation - Google Patents
Cyclosporin formulationInfo
- Publication number
- AU1043201A AU1043201A AU10432/01A AU1043201A AU1043201A AU 1043201 A AU1043201 A AU 1043201A AU 10432/01 A AU10432/01 A AU 10432/01A AU 1043201 A AU1043201 A AU 1043201A AU 1043201 A AU1043201 A AU 1043201A
- Authority
- AU
- Australia
- Prior art keywords
- cyclosporin formulation
- cyclosporin
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
WOIN99/00062 | 1999-11-02 | ||
PCT/IN1999/000062 WO2001032143A1 (en) | 1999-11-02 | 1999-11-02 | A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and a process for preparation thereof |
GB0012816 | 2000-05-25 | ||
GB0012816A GB2362573A (en) | 2000-05-25 | 2000-05-25 | Cyclosporin formulation |
PCT/GB2000/004143 WO2001032142A1 (en) | 1999-11-02 | 2000-10-27 | Cyclosporin formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1043201A true AU1043201A (en) | 2001-05-14 |
Family
ID=26244360
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU10432/01A Abandoned AU1043201A (en) | 1999-11-02 | 2000-10-27 | Cyclosporin formulation |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1227793A1 (en) |
AU (1) | AU1043201A (en) |
WO (1) | WO2001032142A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0008785D0 (en) * | 2000-04-10 | 2000-05-31 | Novartis Ag | Organic compounds |
GB2391471B (en) * | 2002-08-02 | 2005-05-04 | Satishchandra Punambhai Patel | Pharmaceutical compositions |
US20050059583A1 (en) | 2003-09-15 | 2005-03-17 | Allergan, Inc. | Methods of providing therapeutic effects using cyclosporin components |
FR2873923B1 (en) * | 2004-08-05 | 2007-01-12 | Gattefosse Holding Sa | ANHYDROUS SOLID PARTICLE CONTAINING A LIQUID LIPIDIC COMPOSITION AND PHARMACEUTICAL COMPOSITION CONTAINING SAID PARTICLES |
WO2006085217A2 (en) * | 2005-02-08 | 2006-08-17 | Pfizer Products Inc. | Solid adsorbates of hydrophobic drugs |
US7501393B2 (en) | 2005-07-27 | 2009-03-10 | Allergan, Inc. | Pharmaceutical compositions comprising cyclosporins |
US9839667B2 (en) | 2005-10-14 | 2017-12-12 | Allergan, Inc. | Prevention and treatment of ocular side effects with a cyclosporin |
US7745400B2 (en) | 2005-10-14 | 2010-06-29 | Gregg Feinerman | Prevention and treatment of ocular side effects with a cyclosporin |
EP2380564B1 (en) | 2007-04-04 | 2014-10-22 | Sigmoid Pharma Limited | An oral pharmaceutical composition |
ES2528421T3 (en) * | 2008-10-22 | 2015-02-09 | Santen Pharmaceutical Co., Ltd | Pharmaceutical composition of better absorption through the intestinal tract |
ES2649112T3 (en) | 2009-05-18 | 2018-01-10 | Sigmoid Pharma Limited | Composition comprising drops of oil |
IN2012DN00781A (en) | 2009-08-12 | 2015-06-26 | Sigmoid Pharma Ltd | |
GB201020032D0 (en) | 2010-11-25 | 2011-01-12 | Sigmoid Pharma Ltd | Composition |
GB201304662D0 (en) | 2013-03-14 | 2013-05-01 | Sigmoid Pharma Ltd | Compositions |
BR112017009510A2 (en) | 2014-11-07 | 2017-12-19 | Sigmoid Pharma Ltd | compositions comprising cyclosporine |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2222770B (en) * | 1988-09-16 | 1992-07-29 | Sandoz Ltd | Pharmaceutical compositions containing cyclosporins |
KR0146671B1 (en) * | 1994-02-25 | 1998-08-17 | 김충환 | Cyclosporin-containing powder composition |
EP0760237A1 (en) * | 1995-08-30 | 1997-03-05 | Cipla Limited | Oil-in-water microemulsions |
WO1998040051A1 (en) * | 1997-03-12 | 1998-09-17 | Abbott Laboratories | Lipophilic binary systems for the administration of lipophilic compounds |
ID25908A (en) * | 1998-03-06 | 2000-11-09 | Novartis Ag | EMULSION PRACTONCENTRATES CONTAINING CYCLOSPORINE OR MACROLIDES |
-
2000
- 2000-10-27 AU AU10432/01A patent/AU1043201A/en not_active Abandoned
- 2000-10-27 WO PCT/GB2000/004143 patent/WO2001032142A1/en not_active Application Discontinuation
- 2000-10-27 EP EP00971598A patent/EP1227793A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1227793A1 (en) | 2002-08-07 |
WO2001032142A1 (en) | 2001-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3243300A (en) | Multiparticulate formulation | |
AUPP970099A0 (en) | Concrete formulation | |
AU7998900A (en) | Automotive-ceiling-mounted monitor | |
AU1173201A (en) | Skin-gripper | |
EG24226A (en) | Formulation | |
AU4328800A (en) | Pharmaceutical formulation | |
AU1043201A (en) | Cyclosporin formulation | |
AUPQ147699A0 (en) | Sunscreen formulations | |
AU2792700A (en) | Pharmaceutical composition containing cyclosporin | |
GB9905898D0 (en) | Controlled-dose formulation | |
GB9902304D0 (en) | Formulation | |
AU2804600A (en) | Arylaminoalkylamides | |
AU2023701A (en) | Sketcher | |
AU2699800A (en) | Organoceramics | |
AU3303300A (en) | Cleaning formulation | |
AU3191100A (en) | Ligand-bonded complex | |
AU3839900A (en) | Pharmaceutical formulation | |
AU4081300A (en) | Centroid integration | |
AU3930399A (en) | Cyclosporin preparations | |
GB9927614D0 (en) | Sterliant formulation | |
AU1901801A (en) | Glucofuranoses | |
AU1388501A (en) | Pharmaceutical formulation | |
AU2582200A (en) | Windturbine | |
AU1915601A (en) | Periotome | |
AU2197301A (en) | Microlamp |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |